GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Accounts Payable

Shandong Boan Biotechnology Co (HKSE:06955) Accounts Payable : HK$238.0 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Accounts Payable?

Shandong Boan Biotechnology Co's Accounts Payable for the quarter that ended in Dec. 2023 was HK$238.0 Mil.

Shandong Boan Biotechnology Co's quarterly Accounts Payable increased from Dec. 2022 (HK$178.9 Mil) to Jun. 2023 (HK$186.5 Mil) and increased from Jun. 2023 (HK$186.5 Mil) to Dec. 2023 (HK$238.0 Mil).

Shandong Boan Biotechnology Co's annual Accounts Payable increased from Dec. 2021 (HK$169.9 Mil) to Dec. 2022 (HK$178.9 Mil) and increased from Dec. 2022 (HK$178.9 Mil) to Dec. 2023 (HK$238.0 Mil).


Shandong Boan Biotechnology Co Accounts Payable Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Accounts Payable Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accounts Payable
108.57 169.85 178.90 237.98

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable Get a 7-Day Free Trial 169.85 141.30 178.90 186.55 237.98

Shandong Boan Biotechnology Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Shandong Boan Biotechnology Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Executives
Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li 2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines